AzTrials
AzTrials

Binge Alcohol ConsumptionEA-AvatarNCT07418047

Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults

A study testing EA-Avatar and Suicide safety planning app in people with Binge Alcohol Consumption and Suicidal Ideation, run by University of Massachusetts, Worcester at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn whether a novel digital avatar (virtual coach) support program can help emerging adults ages 18-29 who present to the emergency department with suicidal thoughts and alcohol misuse (EA-Avatar). Read more about this study

Who is it for?
Ages 18 to 29 years
Conditions the study is for
Binge Alcohol Consumption, Suicidal Ideation
What is being tested?
EA-Avatar and Suicide safety planning app
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesUnited States
Study dates
10 Jun 2026to 31 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • (1) emergency department admission for alcohol- or suicide-related reason since turning 18, OR treated for incidental suicide risk in the emergency department
  • (2) aged 18-29
  • (3) speak, read, and understand English
  • (4) binge drinking in the past month OR alcohol use problems (Alcohol Use Disorders Identification Test score > 5)
  • (5) active suicidal ideation in the past month
  • (6) owning and having access to a personal smartphone
  • (7) willingness to be randomized to an avatar guided intervention for alcohol use problems and suicidal thoughts OR a freely available suicide safety planning app
  • (8) for remote MyChart-based recruitment only, have MyChart activated

Who cannot join

  • (1) severe cognitive delay, active psychosis, or heavy intoxication that precludes research participation
  • (2) imminent safety risk and have been recently unsafe to themselves or others
  • (3) prisoner or are under arrest
  • (4) not interested or not willing to be randomized to receive the avatar-guided digital intervention or safety plan app
  • (5) under the care of a legal guardian

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United States2 sites, 2 recruiting
  • UMass Memorial Health - Marlborough Hospital

    Marlborough, Massachusetts, 01752

    Lourah M Kelly, PhD, 508-948-8973, lourah.kelly@umassmed.edu

    Lourah M Kelly, PhD

    Recruiting
  • UMass Memorial Health - University Campus

    Worcester, Massachusetts, 01545

    Lourah M Kelly, PhD, 508-948-8973, lourah.kelly@umassmed.edu

    Lourah M Kelly, PhD

    Recruiting

Other trials in United States

About this study

Official title: Randomized Controlled Feasibility Trial of an Avatar Guided Intervention for Young Adults Seen in the Emergency Department With Alcohol Use Problems and Suicidal Thoughts

The goal of this clinical trial is to learn whether a novel digital avatar (virtual coach) support program can help emerging adults ages 18-29 who present to the emergency department with suicidal thoughts and alcohol misuse (EA-Avatar). The study also aims to learn whether people find the program easy to use and whether daily surveys and the study design are able to be completed by the majority of emerging adult participants.

The main questions this study aims to answer are:

Read more
  • Do participants use the digital program and find it helpful?
  • Is it possible for participants to complete daily surveys for twenty-eight days and follow-up surveys over twelve weeks?
  • Are there early signs that the program may help lower alcohol use and suicidal thoughts?

Researchers will compare participants who receive the new digital avatar program plus supportive text messages to participants who receive a freely available suicide safety planning app to see if there are differences in use, engagement, and early signs of benefit.

Participants will:

  • Receive standard care from the emergency department
  • Be randomly put into one of two groups (EA-Avatar or a free suicide prevention app)
  • Depending on their group, use a new avatar-guided digital support program with text message reminders OR use a free suicide safety planning app
  • Complete surveys at the start of the study and again at four, eight, and twelve weeks
  • Complete short daily surveys for twenty-eight days
Read the detailed description

This study is a randomized controlled feasibility study with emerging adults presenting to the emergency department with alcohol misuse and suicidal ideation, to test the acceptability, feasibility, safety, and initial efficacy of a newly developed digital intervention, as well as the feasibility of research protocols.

Sixty emerging adults aged 18-29 who have received care in the emergency department for alcohol use problems and/or suicidal thoughts will be recruited and asked to complete assessments at baseline, four weeks, eight weeks, and twelve weeks, as well as twenty-eight consecutive days of daily diary surveys. Half of participants will be given access to a newly designed avatar-guided digital intervention and text message intervention for emerging adults(EA-Avatar), while half will receive a freely available suicide safety planning app. Exclusion criteria are conditions that would preclude research participation (e.g., cognitive disabilities, in police custody; under guardianship; at imminent risk of harming oneself in the emergency department).

Participants will complete measures of alcohol use, suicidal ideation, and alcohol-related cognitions and experiences, as well as service utilization. They will also complete a scale of acceptability of the avatar intervention and qualitative interviews of the intervention and research protocols.

Primary aims include participant acceptability of the intervention as rated by satisfaction surveys and feasibility of study procedures and assessments as defined by completion of follow-up assessment and daily surveys for 28 days. Secondary aims include early signals of potential effects on alcohol use severity, binge drinking days, and suicidal ideation severity, as well as safety as defined by adverse and serious adverse events and worsening of alcohol use problems or suicidal ideation severity from baseline to 12 weeks.

Being tested
EA-Avatar, Suicide safety planning app
Keywords
suicidal ideation, binge drinking, emerging adults, feasibility, emergency department, digital health
Medical subject headings
Binge Drinking, Suicidal Ideation, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EA-AvatarBehavioural

    The avatar-guided digital intervention includes monitoring of alcohol use and triggers of suicidal thoughts, skills to manage alcohol use and suicidal thoughts, resources on how to access outpatient care and crisis hotlines for suicidal thoughts, and achievements for milestones. In addition, text messages with inspirational quotes and reminders to access the avatar platform are used to support engagement and foster hope. They are also given any emergency department care and/or follow-up and referral services they would otherwise receive and can continue any other behavioral health care.

  • Suicide safety planning appBehavioural

    A publicly available suicide safety planning app which includes guidance on creating a Stanley-Brown Safety Plan, including warning signs, things users can do on their own when feeling suicidal, people who can distract them, people who can support them, professionals or organizations who can support them, and reasons for living.

Study groups in NCT07418047
Study groupRoleWhat they receive
Avatar guided digital health intervention for emerging adults (EA-Avatar)ExperimentalThe avatar-guided digital intervention includes monitoring of alcohol use and triggers of suicidal thoughts, skills to manage alcohol use and suicidal thoughts, resources on how to access outpatient care and crisis hotlines for suicidal thoughts, and achievements for milestones. In addition, text messages with inspirational quotes and reminders to access the avatar platform are used to support engagement and foster hope. They are also given any emergency department care and/or follow-up and referral services they would otherwise receive and can continue any other behavioral health care.
Receives: Behavioral: EA-Avatar
Suicide safety plan appActive comparatorParticipants are given information to download a freely available suicide safety planning app. They are also given any emergency department care and/or follow-up and referral services they would otherwise receive and can continue any other behavioral health care.
Receives: Behavioral: Suicide safety planning app

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability as defined by positive ratings on the WAI-TECH-SF

    Positive ratings on the Working Alliance Inventory Technology Version, Short Form (WAI-TECH-SF) as measured by an average of 4 out of 7 or higher on the mean score. Minimum = 1, Maximum = 7, higher scores mean better acceptability

    Measured: 12 weeks

  2. Feasibility of research protocols, defined as follow-up retention

    Feasibility will be supported by retention of research participants in at least 80% at each of the four assessments

    Measured: 12 weeks

  3. Feasibility of research protocols, defined as adherence to the ecological momentary assessment/daily diary protocol

    Feasibility will be supported by at least 75% of total daily diary surveys across 28 days

    Measured: 28 days

Secondary outcomes (5)
  1. Safety, as defined by number of adverse events in each arm

    Number of adverse events in each arm over 12 weeks

    Measured: 12 weeks

  2. Safety, as defined by serious adverse events in each arm

    Safety as defined by serious adverse events in each arm over 12 weeks

    Measured: 12 weeks

  3. Safety as defined by worsening of drinking and suicidal ideation severity

    Safety as defined by worsening of alcohol use problems or suicidal ideation severity from baseline to 12 weeks, in increases of the sample standard deviation in either problem

    Measured: 12 weeks

  4. Initial efficacy in binge drinking days, defined as days of binge drinking on the Time Line Follow-Back

    Decreases in days of binge drinking in the past 90 days, as reported on the Time Line Follow Back from Baseline to 12 weeks

    Measured: 12 weeks

  5. Early efficacy in suicidal ideation severity, as defined by Beck Suicide Scale scores

    Decreases in severity of suicidal ideation in the past month, as reported on the Beck Suicide Scale items 1-19, from Baseline to 12 weeks, Minimum score = 0, maximum score = 57.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2026
  2. Study start10 Jun 2026
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07418047
Sponsor's protocol ID
002997
Other IDs
R00AA029154
Acronym
EA-Avatar
Status last verified
Jul 2026
First submitted
10 Feb 2026
Last updated
3 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data will be shared with per reasonable request to the PI, after the final report and data is published in a peer-reviewed scientific journal. Data will also be submitted to the National Data Archive.

Questions about this trial

What is this clinical trial studying?

A study testing EA-Avatar and Suicide safety planning app in people with Binge Alcohol Consumption and Suicidal Ideation, run by University of Massachusetts, Worcester at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability as defined by positive ratings on the WAI-TECH-SF (time frame: 12 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in